Literature DB >> 24746217

Benign perivascular myoid cell tumor (myopericytoma) of the urinary tract: a report of 2 cases with an emphasis on differential diagnosis.

Ming Zhao1, Sean R Williamson2, Ke Sun3, Yin Zhu1, Changshui Li1, Wenping Xia4, Honggang Qi5, Lisha Wang6, Konstantinos Linos7, Liang Cheng8.   

Abstract

Myopericytoma is a benign mesenchymal neoplasm thought to comprise part of a spectrum of perivascular myoid cell neoplasms with myofibroma, angioleiomyoma, and glomus tumor. We describe 2 such neoplasms involving the urinary tract: 1 incidentally identified in the kidney of a 59-year-old woman and 1 in the urinary bladder of a 52-year-old woman who presented with urinary frequency and dysuria. Histologically, the bladder tumor was composed of numerous blood vessels surrounded by plump perivascular myoid cells, as in subcutaneous myopericytoma. The renal tumor showed similar morphology centrally and a symplastic glomus tumor-like growth pattern at the periphery. Immunohistochemically, both tumors were reactive for markers of smooth muscle differentiation, such as smooth muscle actin and caldesmon/calponin but negative for CD34, cathepsin K, and S100 protein. Both patients are free of disease 14 and 39 months after resection, respectively. Our findings broaden the morphologic spectrum of myopericytoma.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Differential diagnosis; Glomus tumor; Immunohistochemistry; Kidney; Mesenchymal tumor; Myopericytoma; Urinary bladder

Mesh:

Substances:

Year:  2014        PMID: 24746217     DOI: 10.1016/j.humpath.2013.12.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

Review 1.  [Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma : Case report and literature review].

Authors:  N Muro Bushart; L Tharun; R Oheim; A Paech; J Kiene
Journal:  Orthopade       Date:  2020-01       Impact factor: 1.087

2.  Clinico-pathological features of gynecological myopericytoma: a challenging diagnosis in an exceptional location.

Authors:  Fulvio Borella; Fabiola Lucchino; Luca Bertero; Marisa Ribotta; Isabella Castellano; Andrea Carosso; Stefano Cosma; Dionyssios Katsaros; Chiara Benedetto
Journal:  Virchows Arch       Date:  2019-08-13       Impact factor: 4.064

Review 3.  Renal myopericytoma: a clinicopathologic study of six cases and review of the literature.

Authors:  Jun Li; Ming Zhao; Zhen Chen; Liang Zou; Xiaodong Teng
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  [Mesenchymal tumors of the urinary bladder].

Authors:  A Agaimy; A Hartmann
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

5.  Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.

Authors:  Myung-Shin Lee; Jisu Lee; Joo Heon Kim; Won Tae Kim; Wun-Jae Kim; Hanjong Ahn; Jinsung Park
Journal:  Oncotarget       Date:  2015-11-24

6.  Myopericytoma occurrence in the liver and stomach space: imaging performance.

Authors:  Zhihua Chen; Wenjie Liang
Journal:  BMC Cancer       Date:  2017-02-20       Impact factor: 4.430

7.  Myopericytoma in urinary bladder: a case report.

Authors:  Takahiro Nagai; Toshio Kamimura; Kaoru Itou; Masato Fujii; Hiromasa Tsukino; Shoichiro Mukai; Yutaka Akiyama; Hiroaki Kataoka; Toshiyuki Kamoto
Journal:  J Med Case Rep       Date:  2017-02-19

8.  Foot soft tissue myopericytoma: Case-report and review.

Authors:  D Provenzano; S Lo Bianco; M Belfiore; A Buffone; M A Cannizzaro
Journal:  Int J Surg Case Rep       Date:  2017-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.